Immunovant(IMVT) - 2023 Q2 - Earnings Call Presentation

IMMUNOVANT 2 | --- | --- | --- | --- | --- | |----------------------------------------------------------------------------------------------------------------------------------------|------------|-------|-------|-------| | | | | | | | What we do: | | | | | | We are developing targeted therapies that are designed to address the complex and variable needs of people with autoimmune diseases. | | | | | | | | | | | | Love Trailblazing | All Voices | | | | autoimmune disease indications Differentiated product can ...